Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model
暂无分享,去创建一个
[1] R. L. Jones,et al. The effect of ionic strength on DNA-ligand unwinding angles for acridine and quinoline derivatives. , 1980, Nucleic acids research.
[2] P. Jones,et al. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810] , 2002, BMC complementary and alternative medicine.
[3] J N Weinstein,et al. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. , 1998, Journal of medicinal chemistry.
[4] T. Yamori,et al. In vitro cytotoxicity of the protoberberine-type alkaloids. , 2001, Journal of natural products.
[5] A. R. Srinivasan,et al. Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs. , 1997, Biochemistry.
[6] P. Pantazis,et al. The camptothecins : from discovery to the patient , 1996 .
[7] P. Canal,et al. Toxicity Patterns of Cytotoxic Drugs , 2003, Investigational New Drugs.
[8] H. Strutt,et al. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. , 1991, Nucleic acids research.
[9] Y. Pommier,et al. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. , 2002, Biochemistry.
[10] F. Arvelo,et al. Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro. , 2000, Journal of ethnopharmacology.
[11] A. Clark,et al. Antimicrobial properties of alkaloids from Xanthorhiza simplicissima. , 1994, Journal of pharmaceutical sciences.
[12] J. Champoux,et al. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.
[13] B. Yung,et al. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. , 1995, Cancer letters.
[14] Lance Stewart,et al. The mechanism of topoisomerase I poisoning by a camptothecin analog , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. Wilson,et al. The interaction of plant alkaloids with DNA. II. Berberinium chloride. , 1977, Nucleic acids research.
[16] Y. Pommier,et al. Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. R. Srinivasan,et al. Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions. , 2000, Biochemistry.
[18] T. Mizukami,et al. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes. , 1995, Planta medica.
[19] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[20] W. Denny,et al. Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons. , 2002, Nucleic acids research.
[21] G. Kuttan,et al. Role of Berberine as an Adjuvant Response Modifier During Tumour Therapy in Mice , 1999 .
[22] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[23] L. Cipak,et al. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells , 2003, The Journal of pharmacy and pharmacology.
[24] S. Moro,et al. Sequence-specific interactions of drugs interfering with the topoisomerase-DNA cleavage complex. , 2002, Biochimica et biophysica acta.
[25] G. Chillemi,et al. Structure and hydration of the DNA-human topoisomerase I covalent complex. , 2001, Biophysical journal.
[26] D. S. Pilch,et al. A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin. , 2001, Biochemistry.
[27] Nicholas R. Cozzarelli,et al. DNA topology and its biological effects , 1990 .
[28] Olga Kennard,et al. Systematic analysis of structural data as a research technique in organic chemistry , 1983 .
[29] R. Snapka,et al. SV40 DNA replication intermediates: Analysis of drugs which target mammalian DNA replication , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.
[30] K. Bastow,et al. The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition. , 2000, Anti-cancer drug design.
[31] Luhua Lai,et al. Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..